-
New mental health approach cuts hospital admissions 75 percent
pharmatimes
July 13, 2018
A scheme being tested by the NHS that considers the mental health of patients with long-term conditions is being hailed a success, having reduced related hospital admissions by some 75 percent.
-
NHS under ‘intolerable’ strain
pharmatimes
July 13, 2018
NHS Confederation chief executive Niall Dickson is warning that the NHS is “under intolerable strain”, after the latest performance data continue to show growing demand and missed targets.
-
CQC finds half of A&E services sub-standard over winter
pharmatimes
July 12, 2018
The Care Quality Commission has published a report concluding that some patients visiting A&E departments over the winter period received care that was "wholly unsatisfactory".
-
Vertex and NHS England reach impasse over cystic fibrosis drug price
pharmaceutical-technology
July 12, 2018
Cystic fibrosis (CF)-focused Vertex has declared that its recent negotiations with NHS England regarding the price of its drug Orkambi (ivacaftor+lumacaftor) for CF have been inconclusive.
-
NHS England appoints national clinical advisor for primary care
pharmatimes
July 12, 2018
NHS England has appointed a specialist GP to encourage the spread of innovations that integrate health and social care throughout England.
-
Tax rises needed to boost health and social care funding
pharmatimes
July 11, 2018
Tax rises will likely be needed to keep the quality of health and social care as it is now while the system contends with the growing demands of an ageing demographic, concludes a report by The Institute for Fiscal Studies and the Health Foundation.
-
CQC finds half of A&E services sub-standard over winter
pharmatimes
July 11, 2018
The Care Quality Commission has published a report concluding that some patients visiting A&E departments over the winter period received care that was "wholly unsatisfactory".
-
NICE issues decision on Mylotarg, Besponsa for leukaemia
pharmatimes
July 11, 2018
The National Institute for Health and Care Excellence has issued draft guidelines backing restricted use of Pfizer’s Mylotarg for newly diagnosed acute myeloid leukaemia (AML), but has asked for more information on the firm’s Besponsa for a type of acute
-
May names Hancock as new health and social care secretary
pharmatimes
July 11, 2018
Prime Minister Theresa May has named West Suffolk MP Matt Hancock as the new secretary of state for health and social care.
-
Three cancer treatments approved for use on NHS Scotland
pharmatimes
July 11, 2018
Three treatments have been approved for NHS funding in Scotland, bringing new options for gastroenteropancreatic tumours, lung and kidney cancers, but patients with multiple sclerosis will be unable to access Roche’s Ocrevus following a rejection by the S